HEADER TRANSFERASE 17-SEP-15 5DT4 TITLE AURORA A KINASE IN COMPLEX WITH AA35 AND ATP IN SPACE GROUP P6122 COMPND MOL_ID: 1; COMPND 2 MOLECULE: AURORA KINASE A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 126-390; COMPND 5 SYNONYM: AURORA 2,AURORA/IPL1-RELATED KINASE 1,HARK1,BREAST TUMOR- COMPND 6 AMPLIFIED KINASE,SERINE/THREONINE-PROTEIN KINASE 15,SERINE/THREONINE- COMPND 7 PROTEIN KINASE 6,SERINE/THREONINE-PROTEIN KINASE AURORA-A; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PUBS520; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBAT4 KEYWDS AURORA A KINASE, MITOTIC KINASE, PPI, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.JANECEK,M.ROSSMANN,P.SHARMA,A.EMERY,G.J.MCKENZIE,D.J.HUGGINS, AUTHOR 2 S.STOCKWELL,J.A.STOKES,E.G.ALMEIDA,B.HARDWICK,A.J.NARVAEZ,M.HYVONEN, AUTHOR 3 D.R.SPRING,A.R.VENKITARAMAN REVDAT 2 10-JAN-24 5DT4 1 REMARK REVDAT 1 20-JUL-16 5DT4 0 JRNL AUTH M.JANECEK,M.ROSSMANN,P.SHARMA,A.EMERY,D.J.HUGGINS, JRNL AUTH 2 S.R.STOCKWELL,J.E.STOKES,Y.S.TAN,E.G.ALMEIDA,B.HARDWICK, JRNL AUTH 3 A.J.NARVAEZ,M.HYVONEN,D.R.SPRING,G.J.MCKENZIE, JRNL AUTH 4 A.R.VENKITARAMAN JRNL TITL ALLOSTERIC MODULATION OF AURKA KINASE ACTIVITY BY A JRNL TITL 2 SMALL-MOLECULE INHIBITOR OF ITS PROTEIN-PROTEIN INTERACTION JRNL TITL 3 WITH TPX2. JRNL REF SCI REP V. 6 28528 2016 JRNL REFN ESSN 2045-2322 JRNL PMID 27339427 JRNL DOI 10.1038/SREP28528 REMARK 2 REMARK 2 RESOLUTION. 2.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 8453 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 432 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.20 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.87 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2312 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2525 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2200 REMARK 3 BIN R VALUE (WORKING SET) : 0.2482 REMARK 3 BIN FREE R VALUE : 0.3389 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.84 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 112 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2120 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 53 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 125.4 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 112.4 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.36350 REMARK 3 B22 (A**2) : -0.36350 REMARK 3 B33 (A**2) : 0.72690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.542 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.373 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2236 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3031 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 783 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 48 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 333 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2236 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 271 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2545 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.69 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.58 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5DT4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1000213754. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8500 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.860 REMARK 200 RESOLUTION RANGE LOW (A) : 56.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 18.20 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 18.90 REMARK 200 R MERGE FOR SHELL (I) : 2.21000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3FDN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES PH 7.4, 200 MM MAGNESIUM REMARK 280 SULFATE, 2-20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.67333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 113.34667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 85.01000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 141.68333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.33667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.67333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 113.34667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 141.68333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 85.01000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 28.33667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 124 REMARK 465 GLY A 125 REMARK 465 ARG A 126 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 LEU A 289 REMARK 465 HIS A 391 REMARK 465 HIS A 392 REMARK 465 HIS A 393 REMARK 465 HIS A 394 REMARK 465 HIS A 395 REMARK 465 HIS A 396 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 MG MG A 401 O1A ATP A 403 1.69 REMARK 500 O VAL A 174 O GLU A 175 1.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 175 N - CA - C ANGL. DEV. = -22.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 171 -2.24 -56.84 REMARK 500 GLU A 175 -80.30 -50.26 REMARK 500 HIS A 176 -90.28 23.78 REMARK 500 ASP A 202 -149.11 -135.36 REMARK 500 ALA A 203 -72.59 -49.52 REMARK 500 SER A 226 -53.13 70.17 REMARK 500 ARG A 255 -14.36 66.74 REMARK 500 ASP A 274 87.02 56.58 REMARK 500 ARG A 304 177.77 -55.55 REMARK 500 ASP A 307 -150.61 -128.94 REMARK 500 PHE A 351 2.59 -64.92 REMARK 500 LEU A 364 57.70 -94.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 401 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 261 OD1 REMARK 620 2 ASP A 274 OD2 72.1 REMARK 620 3 ATP A 403 O1B 151.7 80.1 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5DN A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ATP A 403 DBREF 5DT4 A 126 390 UNP O14965 AURKA_HUMAN 126 390 SEQADV 5DT4 MET A 124 UNP O14965 INITIATING METHIONINE SEQADV 5DT4 GLY A 125 UNP O14965 EXPRESSION TAG SEQADV 5DT4 HIS A 391 UNP O14965 EXPRESSION TAG SEQADV 5DT4 HIS A 392 UNP O14965 EXPRESSION TAG SEQADV 5DT4 HIS A 393 UNP O14965 EXPRESSION TAG SEQADV 5DT4 HIS A 394 UNP O14965 EXPRESSION TAG SEQADV 5DT4 HIS A 395 UNP O14965 EXPRESSION TAG SEQADV 5DT4 HIS A 396 UNP O14965 EXPRESSION TAG SEQRES 1 A 273 MET GLY ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY SEQRES 2 A 273 ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU SEQRES 3 A 273 ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS SEQRES 4 A 273 VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU SEQRES 5 A 273 HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU SEQRES 6 A 273 ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS SEQRES 7 A 273 ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO SEQRES 8 A 273 LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS SEQRES 9 A 273 PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU SEQRES 10 A 273 ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE SEQRES 11 A 273 HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER SEQRES 12 A 273 ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL SEQRES 13 A 273 HIS ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR SEQRES 14 A 273 LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET SEQRES 15 A 273 HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU SEQRES 16 A 273 CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA SEQRES 17 A 273 ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL SEQRES 18 A 273 GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG SEQRES 19 A 273 ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN SEQRES 20 A 273 ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE SEQRES 21 A 273 THR ALA ASN SER SER LYS PRO HIS HIS HIS HIS HIS HIS HET MG A 401 1 HET 5DN A 402 21 HET ATP A 403 31 HETNAM MG MAGNESIUM ION HETNAM 5DN 2-(3-BROMOPHENYL)-8-FLUOROQUINOLINE-4-CARBOXYLIC ACID HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 2 MG MG 2+ FORMUL 3 5DN C16 H9 BR F N O2 FORMUL 4 ATP C10 H16 N5 O13 P3 HELIX 1 AA1 ALA A 129 GLU A 131 5 3 HELIX 2 AA2 LYS A 166 LYS A 171 1 6 HELIX 3 AA3 HIS A 176 HIS A 187 1 12 HELIX 4 AA4 THR A 217 SER A 226 1 10 HELIX 5 AA5 ASP A 229 SER A 249 1 21 HELIX 6 AA6 LYS A 258 GLU A 260 5 3 HELIX 7 AA7 THR A 292 LEU A 296 5 5 HELIX 8 AA8 PRO A 297 GLU A 302 1 6 HELIX 9 AA9 LYS A 309 GLY A 325 1 17 HELIX 10 AB1 THR A 333 VAL A 344 1 12 HELIX 11 AB2 THR A 353 LEU A 364 1 12 HELIX 12 AB3 MET A 373 GLU A 379 1 7 HELIX 13 AB4 HIS A 380 SER A 387 1 8 SHEET 1 AA1 5 PHE A 133 LYS A 141 0 SHEET 2 AA1 5 ASN A 146 GLU A 152 -1 O VAL A 147 N LEU A 139 SHEET 3 AA1 5 PHE A 157 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA1 5 ARG A 205 GLU A 211 -1 O LEU A 210 N ALA A 160 SHEET 5 AA1 5 LEU A 196 HIS A 201 -1 N PHE A 200 O TYR A 207 SHEET 1 AA2 2 VAL A 252 ILE A 253 0 SHEET 2 AA2 2 VAL A 279 HIS A 280 -1 O VAL A 279 N ILE A 253 SHEET 1 AA3 2 LEU A 262 LEU A 264 0 SHEET 2 AA3 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 LINK OD1 ASN A 261 MG MG A 401 1555 1555 2.23 LINK OD2 ASP A 274 MG MG A 401 1555 1555 2.60 LINK MG MG A 401 O1B ATP A 403 1555 1555 2.19 CISPEP 1 ALA A 281 PRO A 282 0 0.26 SITE 1 AC1 3 ASN A 261 ASP A 274 ATP A 403 SITE 1 AC2 8 LYS A 166 LEU A 169 GLU A 170 GLU A 175 SITE 2 AC2 8 ARG A 179 TYR A 199 HIS A 201 VAL A 206 SITE 1 AC3 21 LEU A 139 GLY A 140 LYS A 141 GLY A 142 SITE 2 AC3 21 LYS A 143 PHE A 144 VAL A 147 ALA A 160 SITE 3 AC3 21 LYS A 162 GLU A 181 LEU A 194 GLU A 211 SITE 4 AC3 21 ALA A 213 THR A 217 ASP A 256 GLU A 260 SITE 5 AC3 21 ASN A 261 LEU A 263 ASP A 274 GLY A 276 SITE 6 AC3 21 MG A 401 CRYST1 82.500 82.500 170.020 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012121 0.006998 0.000000 0.00000 SCALE2 0.000000 0.013996 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005882 0.00000